
ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data

ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data

Clarivate Analytics predicts both approvals and commercial potential

Now two-plus years on, the dispute over physician databases shows no sign of resolution

Deal with Evoke Pharmaceuticals anticipates FDA approval

Europe leads in trial locations

Too many states have opted out of the $18-billion agreement being negotiated in federal court

TCP will now be known as Integreon Global

A former executive at PhRMA, Davis will now lead the wholesaler-distributor association

TruTrace tackles the marijuana supply chain; potential for pharma traceability

NanoCool’s evaporative cooling technology gains a broader market

CBI meeting will highlight new advances in market access via hub services

Facility maintains the company’s cold-chain air containers, even as it assists in disaster recovery

French health-products distributor EHDH will acquire the asset

New product line features curbside recyclable insulation

Thermo Fisher to provide manufacturing expertise

Transforming the container to an interactive portal


Company has a broad line of traceability-enabled packaging machinery

Location near UPS’ WorldPort hub in Louisville, KY, enables fast prescription turnarounds

ARM-sponsored study projects a 23% reduction in the cost of treating blood diseases in 2029 by administering cellular and genetic therapies

Of NDA/BLA drugs, 45% require cold-chain distribution

Eversana Engage will ‘seamlessly’ integrate marketing support with the company’s commercial services

Packaging materials have an impact in regulatory compliance, patient safety and drug efficacy

Ushering in the Next Decade of Change

PwC Australia, Colorcon and TruTag Technologies collaborate

Trump administration drops its bombshell proposal to open up the US pharmaceutical market

January meeting will bring patient advocates, industry and regulators together

The ‘broken promise’ of lower-cost insulin, according to Senators Warren and Blumenthal

Partnership for DSCSA Governance, Inc. is up and running